Global Influenza Programme
We provide Member States with strategic guidance, technical support and coordination of activities essential to make their health systems better prepared against seasonal, zoonotic and pandemic influenza threats to populations and individuals.

Avian influenza A(H5N1) virus

Avian influenza A(H5N1) is a subtype of influenza virus that infects birds and mammals, including humans in rare instances. The goose/Guangdong-lineage of H5N1 avian influenza viruses first emerged in 1996 and have been causing outbreaks in birds since then. Since 2020, a variant of these viruses belonging to the H5 clade 2.3.4.4b has led to an unprecedented number of deaths in wild birds and poultry in many countries in Africa, Asia and Europe. In 2021, the virus spread to North America, and in 2022, to Central and South America.  

Infections in humans can cause severe disease with a high mortality rate. The human cases detected thus far are mostly linked to close contact with infected birds and other animals and contaminated environments. This virus does not appear to transmit easily from person to person, and sustained human-to-human transmission has not been reported.

Risk assessment and management

Other updates

Technical guidance

Background and summary of human infection with avian influenza A(H5N1) virus

Related content